BASE THERAPEUTICS
Base Therapeutics offers cell and gene editing technology designed to treat cancerous diseases. The company's technology includes a natural killer cell genetic engineering platform and other cell therapy products for treatments of lung cancer, liver cancer, glioma, and other hematological tumors
BASE THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2021-04-28
Address:
Zhuhai, Guangdong, China
Country:
China
Website Url:
http://www.basetherapeutics.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
Chinese Server Location
Similar Organizations
Aristea Therapeutics
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
Baisios
Baisios is a developer of tumor immune cell therapy technology and is dedicated to the growth of the tumor biotherapy industry.
CStone Pharmaceuticals
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Pionyr Immunotherapeutics
Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Susstains
Sustained efforts to create a sustainable ecosystem in the agri-tech and engineering domains.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Investors List
Guangda Huitong
Guangda Huitong investment in Series A - Base Therapeutics
Great Eagle Holdings Limited
Great Eagle Holdings Limited investment in Series A - Base Therapeutics
Sincere Capital
Sincere Capital investment in Series A - Base Therapeutics
Panacea Venture
Panacea Venture investment in Series A - Base Therapeutics
Highlight Capital
Highlight Capital investment in Series A - Base Therapeutics
Baidu Ventures
Baidu Ventures investment in Series A - Base Therapeutics
Official Site Inspections
http://www.basetherapeutics.com Semrush global rank: 8.21 M Semrush visits lastest month: 605
- Host name: 139.196.144.208
- IP address: 139.196.144.208
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Base Therapeutics"
base therapeutics-贝斯生物-上海贝斯昂科
Please contact: [email protected]. Career and Contact. ... Defines, develops, organizes, supervises, and coordinates plans for problem solving activities of the entire organization. 9. …See details»
Base Therapeutics - Crunchbase Company Profile
Base Therapeutics offers cell and gene editing technology designed to treat cancerous diseases. The company's technology includes a natural killer cell genetic engineering platform and other cell therapy products for treatments of …See details»
Base Therapeutics (Zhuhai) Ltd. - Drug pipelines, Patents ... - Patsnap
Nov 4, 2024 www.basetherapeutics.com. Private Company | 2021 | Guangdong Sheng, China | www.basetherapeutics.com. Last update 04 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Base Therapeutics - PitchBook
Base Therapeutics General Information Description. Developer of cell and gene editing technology designed to treat cancerous diseases. The company's technology includes a …See details»
Base Therapeutics (Shanghai) Ltd. - Drug pipelines, Patents, …
Basetherapeutics.com. Private Company | Subsidiary Company | 2022 | Shanghai Shi, China | basetherapeutics.com. Last update 04 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Base Therapeutics (Zhuhai) Ltd. (珠海贝斯昂科科技有限责任公司)
了解Base Therapeutics (Zhuhai) Ltd. (珠海贝斯昂科科技有限责任公司)公司的药物管线，治疗领域，技术平台，以及它的21篇新闻，疾病领域:肿瘤，血液及淋巴系统疾病，免疫系统疾病，技 …See details»
Base Therapeutics - Products, Competitors, Financials, Employees ...
Base Therapeutics. Frequently Asked Questions (FAQ). When was Base Therapeutics founded? Base Therapeutics was founded in 2021. Where is Base Therapeutics's headquarters? Base …See details»
Base Therapeutics - Funding, Financials, Valuation & Investors
Best Bio is a developer of cell therapy products and gene therapy products.See details»
Base Therapeutics | VentureRadar
Similar Companies: ThunderBiotech USA Privately Held We provide a full platform for a complete cancer cure solution to detect, treat and monitor both solid tumor cancers and blood cancers …See details»
Base Therapeutics - Updates, News, Events, Signals & Triggers
Best Bio is a developer of cell therapy products and gene therapy products.See details»
贝斯生物创始人徐天宏博士：立足碱基编辑等底层技术，开发突破 …
Feb 27, 2023 “我希望看到各个公司真正在核心技术上实现‘百花齐放’，带动基因与细胞治疗行业繁荣发展，同时针对目前尚无有效治疗方式的疾病开发创新疗法，造福广大病患。”——贝斯 …See details»
Base Therapeutics - VentureRadar
Similar Companies: Propion Health Unknown Privately Held Propion Health, branded also as How to Slow Time, Inc., is a biotech company focused on developing innovative products aimed at …See details»
Base Therapeutics - Company Profile - Tracxn
Dec 6, 2024 Base Therapeutics - Developer of cell and gene editing technology designed to treat cancerous diseases. Raised funding over 3 rounds from 2 investors. Base Therapeutics …See details»
新闻中心-News Center-base therapeutics-贝斯生物-上海贝斯昂科
Nov 26, 2024 China：1 / F, Building 23, No.200 Jinsu Road, No.700 Jiqiao Road, Pudong New District, Shanghai USA：472 Millfield Place, Moraga, CA 94556, USA HR email: …See details»
NK Cell Therapy Gets IND FDA Clearance with AccuBase® Base …
November 14, 2024 Base Therapeutics announced that its independently developed NK510 cell injection, the world's first base-edited universal NK cell product, has received IND clearance …See details»
Base Therapeutics Out-Licenses Its Proprietary Base Editing …
Jan 22, 2024 The Life Sciences team represented Base Therapeutics in the out-licensing of its proprietary base editing technology on a non-exclusive basis to a leading international …See details»
The World’s First Base-edited NK Cell Therapy Receives IND
Dec 2, 2024 Base Therapeutics announced that its in house-developed NK510 cell injection—the world’s first base-edited universal NK cell product—has received IND approvals …See details»
Base Therapeutics | Globenewswire
Dec 5, 2024 World’s First Zero-Off-Target Base-edited NK Cell Therapy Receives IND Approval in Both China and the U.S. SHANGHAI, China, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Base …See details»
World's First Zero-Off-Target Base-edited NK Cell Therapy …
SHANGHAI, China, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Base Therapeutics has announced that its NK510 cell injection, the world's first zero-off-target base-edited NK cell product, has …See details»
World’s First Zero-Off-Target Base-edited NK Cell Therapy
SHANGHAI, China, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Base Therapeutics has announced that its NK510 cell injection, the world’s first zero-off-target base-edited NK cell product, has …See details»